TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16967147

Group type: EXPERIMENTAL
Intervention: Acetyl-salicylic acid (aspirin)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vitamins (retinol, pyridoxine chlorhydrate, tocopherol acetate)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 14575293

Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Intermittent hemodialysis (IHD)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Subgroup of patients with sepsis and septic shock
Number of subjects: 104
Study: 10409200

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP, 2 micrograms . kg(‐1). min(‐1))
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) + phenylephrine (PE, 0.9 +/‐ 0.15 micrograms . kg(‐1). min(‐1))
Number of subjects: 16

Group type: COMPARATOR
Intervention: 5% glucose
Number of subjects: 16
Study: 7573265

Group type: EXPERIMENTAL
Intervention: Home intervention of four to six visits dealing with psychosocial support and education about health-related habits
Number of subjects: 2235

Group type: COMPARATOR
Intervention: Routine prenatal care
Number of subjects: 2235
Study: 2075082

Group type: EXPERIMENTAL
Intervention: Cefuroxime 1,500 mg plus metronidazole 500 mg (3 doses)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 200 mg (single dose)
Number of subjects: 165
Study: 6163343

Group type: EXPERIMENTAL
Intervention: RIA‐PAP test
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional enzymatic PAP study
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Combination of RIA and enzyme studies
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control men
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control men (age-related)
Number of subjects: 211
Study: 29469046

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) with AMO therapy
Number of subjects: 12
Study: 26655485

Group type: EXPERIMENTAL
Intervention: SPEED questionnaire
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: OSDI questionnaire
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Correlation between OSDI and SPEED
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: ROC analysis of SPEED
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Factor analysis of SPEED
Number of subjects: 657
Study: 25132283

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using high‐viscosity glass‐ionomer (HVGIC) Ketac Molar Easymix
Number of subjects: 280

Group type: COMPARATOR
Intervention: Conventional restorative treatment with amalgam (CRT)
Number of subjects: 280
Study: 22642688

Group type: EXPERIMENTAL
Intervention: Human-voiced agent with human-like gestures, facial expression, eye gaze, and body movement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Human-voiced agent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highly embodied agent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inconsistent agent characteristics
Number of subjects: 0
Study: 20124127

Group type: EXPERIMENTAL
Intervention: Intracoronary eptifibatide administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous eptifibatide administration
Number of subjects: 0
Study: 17880431

Group type: EXPERIMENTAL
Intervention: Two additional photographs illustrating the two key steps of the procedure
Number of subjects: 28

Group type: COMPARATOR
Intervention: No further explanation of the reconstitution device
Number of subjects: 28
Study: 16197659

Group type: EXPERIMENTAL
Intervention: Fenofibrate plus colesevelam HCl
Number of subjects: 129

Group type: COMPARATOR
Intervention: Fenofibrate monotherapy
Number of subjects: 129
Study: 11998963

Group type: EXPERIMENTAL
Intervention: Transdermal therapy (17beta‐estradiol 0.05 mg/d + norethisterone acetate 0.25 mg/d)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Oral therapy (conjugated equine estrogens 0.625 mg/d + medroxyprogesterone acetate 10 mg/d)
Number of subjects: 96
Study: 9637637

Group type: EXPERIMENTAL
Intervention: Fentanyl-controlled ventilation group (200 microg fentanyl: two doses of 50 microg and one dose of 100 microg, spaced 6 min)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fentanyl-spontaneous ventilation group (200 microg fentanyl)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Propofol group (propofol alone)
Number of subjects: 22
Study: 8089541

Group type: EXPERIMENTAL
Intervention: Ondansentron alone (Group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ondansentron plus methylprednisolone (Group B)
Number of subjects: 80
Study: 2678520

Group type: EXPERIMENTAL
Intervention: Triampur (TP) - 2 tablets containing 12.5 mg HCT and 25 mg T each
Number of subjects: 57

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) - 25 mg
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Triampur (TP) - doubled doses
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Triampur (TP)
Number of subjects: 57
Study: 811075

Group type: EXPERIMENTAL
Intervention: Carbamazepine alone
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Carbamazepine in combination with phenobarbital and diphenylhydantoin
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 117
Study: 31160244

Group type: EXPERIMENTAL
Intervention: Internet-delivered Cognitive Behaviour Therapy (iCBT) for Fear of Birth
Number of subjects: 19

Group type: COMPARATOR
Intervention: Midwifery led counselling (standard care)
Number of subjects: 19
Study: 30394805

Group type: EXPERIMENTAL
Intervention: Daflon(R) for 1 month
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Daflon(R) for 3 months
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 450
Study: 28427806

Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ghrelin, IL-6, TNF-α
Number of subjects: 52
Study: 25919978

Group type: EXPERIMENTAL
Intervention: Pain interference during treatment in UKATT
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Pain interference during treatment in COMBINE
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Pain interference following treatment in COMBINE
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Pain interference during treatment in UKATT (after controlling for other factors)
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Pain interference following treatment in COMBINE (after controlling for other factors)
Number of subjects: 2125
Study: 24598948

Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (no beta-blockers)
Number of subjects: 68
Study: 21609527

Group type: EXPERIMENTAL
Intervention: Apical hypertrophic cardiomyopathy (AHCM)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Typical hypertrophic cardiomyopathy (OHCM)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Cardiac magnetic resonance imaging
Number of subjects: 160
Study: 19170990

Group type: EXPERIMENTAL
Intervention: Social support condition (donate with a supportive research assistant)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard donation controls (donate as usual)
Number of subjects: 65
Study: 16424650

Group type: EXPERIMENTAL
Intervention: 20 mg ferrous iron supplement (as fumarate)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: 40 mg ferrous iron supplement (as fumarate)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: 60 mg ferrous iron supplement (as fumarate)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: 80 mg ferrous iron supplement (as fumarate)
Number of subjects: 404
Study: 15231459

Group type: EXPERIMENTAL
Intervention: Absorbable plain gut sutures (group A)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Nonabsorbable nylon sutures (group NA)
Number of subjects: 95
Study: 11167166

Group type: EXPERIMENTAL
Intervention: Algorithm with on-site hemostasis monitoring (group A)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Clinician's judgement (group B)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 9247455

Group type: EXPERIMENTAL
Intervention: Small bowel enteroclysis (SBE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Small bowel follow-through (SBFT)
Number of subjects: 26
Study: 7664435

Group type: EXPERIMENTAL
Intervention: d-sotalol 200 mg BID
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: d-sotalol 50 mg BID
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: d-sotalol 100 mg BID
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233
Study: 2665687

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Pimozide
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 360238

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 31142156

Group type: COMPARATOR
Intervention: Hormone therapy (HT) with conjugated estrogens/medroxyprogesterone acetate (0.30 mg/1.5 mg/d)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Acupuncture (weekly for 3 months)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Phytoestrogens (soy isoflavones 75 mg/2/d for 3 months)
Number of subjects: 75
Study: 29390421

Group type: EXPERIMENTAL
Intervention: Celecoxib-based chemotherapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Celecoxib-based chemotherapy (in patients with positive COX-2)
Number of subjects: 240
Study: 24911964

Group type: EXPERIMENTAL
Intervention: 7 mg lycopene daily for 2 months
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 23221015

Group type: EXPERIMENTAL
Intervention: Silk-like textile for bedding paired with high-absorbency adult incontinence briefs
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care with plain-weave cotton/polyester bed sheets and adult incontinence briefs
Number of subjects: 46
Study: 20347837

Group type: EXPERIMENTAL
Intervention: 12 weekly classes of yoga
Number of subjects: 262

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 262
Study: 18981306

Group type: EXPERIMENTAL
Intervention: ONBEAT (on-pump beating heart CABG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: ONSTOP (conventional on-pump CABG)
Number of subjects: 50
Study: 16477954

Group type: EXPERIMENTAL
Intervention: Morphine (intravenous injections of 0.1 mg/kg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (intravenous injections of 0.9% NaCl)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Untreated (baseline)
Number of subjects: 7
Study: 12785319

Group type: COMPARATOR
Intervention: 200 gram tension on extraocular muscle (EOM)
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: 50 gram tension on one muscle
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: 400 gram tension on another muscle
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: Waiting 3 minutes after profound initial OCR
Number of subjects: 842
Study: 10500826

Group type: EXPERIMENTAL
Intervention: High anthracycline dose intensity (H/A)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Low anthracycline dose intensity (L/A)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Allogeneic marrow transplant (allo‐BMT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Favorable prognostic factors (FPF) 0-1
Number of subjects: 76

Group type: COMPARATOR
Intervention: Favorable prognostic factors (FPF) 2-3
Number of subjects: 76

Group type: COMPARATOR
Intervention: Favorable prognostic factors (FPF) 4
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Age < 50 years
Number of subjects: 76
Study: 7797827

Group type: EXPERIMENTAL
Intervention: Mesalazine 250 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 2403448

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 to 20 mg by mouth twice a day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tamoxifen 40 mg by mouth four times a day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tumor tissue assay for estrogen and progesterone receptors
Number of subjects: 12
Study: 343739

Group type: EXPERIMENTAL
Intervention: Moderate hemodilution (mean hematocrit 27%)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Extreme hemodilution (mean hematocrit 18%)
Number of subjects: 29
Study: 31276840

Group type: EXPERIMENTAL
Intervention: Mother's voice alarm
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Female stranger's voice alarm
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Low-frequency 500 Hz square wave tone alarm
Number of subjects: 176

Group type: COMPARATOR
Intervention: Conventional residential high-frequency tone alarm
Number of subjects: 176
Study: 30921595

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 104
Study: 27590412

Group type: EXPERIMENTAL
Intervention: CCM through two leads (Group A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CCM through one lead (Group B)
Number of subjects: 48
Study: 26321103

Group type: EXPERIMENTAL
Intervention: Cyclosporine (2.5 mg/kg IV bolus before PCI)
Number of subjects: 970

Group type: COMPARATOR
Intervention: Placebo (matching placebo before PCI)
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 970

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 970
Study: 23570538

Group type: EXPERIMENTAL
Intervention: Inpatient hybrid closed-loop therapy (HCLC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Outpatient sensor‐augmented pump (SAP) therapy
Number of subjects: 48
Study: 21838198

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19776092

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate/minocycline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Glatiramer acetate/placebo
Number of subjects: 44
Study: 16507199

Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Liver surgery (control group)
Number of subjects: 19
Study: 15636296

Group type: EXPERIMENTAL
Intervention: Ventilation with change of ventilator circuits every 48 hours
Number of subjects: 304

Group type: COMPARATOR
Intervention: Ventilation with no change of circuits
Number of subjects: 304
Study: 11374283

Group type: EXPERIMENTAL
Intervention: Group A (n = 12): Donor cornea fixed in the same position as the recipient
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Group B (n = 12): Donor corneas transplanted with the axis in opposition to the axis of the recipient
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Group C (n = 14): Donor corneas transplanted in the same orientation as the recipient
Number of subjects: 38

Group type: COMPARATOR
Intervention: Group D (n = 40): Control group
Number of subjects: 38
Study: 9232210

Group type: EXPERIMENTAL
Intervention: AMPT (1 g p.o. T.I.D.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8388356

Group type: EXPERIMENTAL
Intervention: Venography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized venographic technique
Number of subjects: 0
Study: 3434164

Group type: EXPERIMENTAL
Intervention: Clonidine (4.5 micrograms kg‐1)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standardized general anaesthesia (Control)
Number of subjects: 21
Study: 28177489

Group type: EXPERIMENTAL
Intervention: mTHS (Tobacco Heating System 2.2)
Number of subjects: 160

Group type: COMPARATOR
Intervention: mCC (menthol conventional cigarettes)
Number of subjects: 160

Group type: COMPARATOR
Intervention: SA (smoking abstinence)
Number of subjects: 160
Study: 26940165

Group type: EXPERIMENTAL
Intervention: Estrogen alone (0.625 mg/day)
Number of subjects: 4347

Group type: COMPARATOR
Intervention: Estrogen plus progestin (medroxyprogesterone acetate 2.5 mg/day)
Number of subjects: 4347
Study: 25465830

Group type: EXPERIMENTAL
Intervention: CCU admission
Number of subjects: 5094

Group type: COMPARATOR
Intervention: Ward admission
Number of subjects: 5094

Group type: COMPARATOR
Intervention: Regional comparison (AP, CE, LA, WE) vs NA CCU patients
Number of subjects: 5094
Study: 22483183

Group type: EXPERIMENTAL
Intervention: Trigger point acupuncture
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 16
Study: 19910076

Group type: EXPERIMENTAL
Intervention: DCT/CDDP (cisplatin 75 mg/m² plus docetaxel 75 mg/m² on day 1 every week)
Number of subjects: 76

Group type: COMPARATOR
Intervention: VNR/CDDP (cisplatin 80 mg/m² on day 1 plus vinorelbine 30 mg/m² on day 1 and 8 every 3 weeks)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: DCT/CDDP
Number of subjects: 76

Group type: COMPARATOR
Intervention: VNR/CDDP
Number of subjects: 76
Study: 18403492

Group type: EXPERIMENTAL
Intervention: Temozolomide for 5 days in 28-day cycles, daily thalidomide, and celecoxib
Number of subjects: 50
Study: 16007352

Group type: EXPERIMENTAL
Intervention: Dermal island flap anoplasty (IFA)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional treatment (CVN)
Number of subjects: 79
Study: 12963897

Group type: EXPERIMENTAL
Intervention: Clindamycin plus adapalene
Number of subjects: 249

Group type: COMPARATOR
Intervention: Clindamycin plus vehicle
Number of subjects: 249
Study: 11022366

Group type: EXPERIMENTAL
Intervention: On-site presentations led by a cardiologist and a quality improvement specialist
Number of subjects: 1367

Group type: COMPARATOR
Intervention: Mailed feedback
Number of subjects: 1367
Study: 8799513

Group type: EXPERIMENTAL
Intervention: Sparfloxacin 200 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sparfloxacin 400 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1386063

Group type: EXPERIMENTAL
Intervention: Betagen, 20 micrograms
Number of subjects: 220

Group type: COMPARATOR
Intervention: Lanzhou, 20 micrograms
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Betagen, 20 micrograms + HBIG
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Betagen, 10 micrograms + HBIG
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Betagen alone
Number of subjects: 220

Group type: COMPARATOR
Intervention: Lanzhou
Number of subjects: 220
Study: 6480923

Group type: EXPERIMENTAL
Intervention: Selenium sulfide lotion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 20
Study: 30621711

Group type: EXPERIMENTAL
Intervention: Psoralen treatment in experimental group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline treatment in blank and model groups
Number of subjects: 30

Group type: COMPARATOR
Intervention: Experimental group vs. Model group
Number of subjects: 30
Study: 30159944

Group type: EXPERIMENTAL
Intervention: Demand-side intervention providing in-kind transfers to users of three services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cooperative performance payments to community health worker cooperatives
Number of subjects: 0
Study: 27193737

Group type: EXPERIMENTAL
Intervention: Mindfulness‐based cancer recovery (MBCR)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Supportive expressive group therapy (SET)
Number of subjects: 252
Study: 23924046

Group type: EXPERIMENTAL
Intervention: Technology-Enhanced HNC (TE-HNC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard HNC
Number of subjects: 15
Study: 22682024

Group type: EXPERIMENTAL
Intervention: Interceptor long-lasting insecticidal nets (200 mg/m² alpha-cypermethrin)
Number of subjects: 936

Group type: COMPARATOR
Intervention: Untreated polyester net (100 denier)
Number of subjects: 936

Group type: COMPARATOR
Intervention: No net
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Interceptor long-lasting insecticidal nets
Number of subjects: 936
Study: 19531246

Group type: EXPERIMENTAL
Intervention: Project Tomato intervention to support maintenance of fruit intake in Year 3 children.
Number of subjects: 54

Group type: COMPARATOR
Intervention: 5 A DAY booklet (control group).
Number of subjects: 54
Study: 17698804

Group type: EXPERIMENTAL
Intervention: High-dose sequential chemotherapy with PBSC support (two cycles of cyclophosphamide and paclitaxel followed by three cycles of HD carboplatin and paclitaxel with PBSC support, HD melphalan added to the final cycle)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard combination chemotherapy
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: High-dose sequential chemotherapy with PBSC support
Number of subjects: 149
Study: 15155714

Group type: EXPERIMENTAL
Intervention: Prolonged exhaustive cycling exercise
Number of subjects: 8
Study: 11476777

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG IUS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endometrial resection
Number of subjects: 60
Study: 9620526

Group type: EXPERIMENTAL
Intervention: epinephrine 15 microg + isoproterenol 1.5 microg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: epinephrine 7.5 microg + isoproterenol 3 microg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: isoproterenol 3 microg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: epinephrine 15 microg
Number of subjects: 75

Group type: COMPARATOR
Intervention: saline
Number of subjects: 75
Study: 7799108

Group type: EXPERIMENTAL
Intervention: Calcium antagonist (nicardipine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiazide diuretic (trichlormethiazide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3260167

Group type: EXPERIMENTAL
Intervention: Flexin Continus
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Indocid R
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30191883

Group type: EXPERIMENTAL
Intervention: Adjuvant Radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salvage Radiotherapy
Number of subjects: 0
Study: 26580093

Group type: EXPERIMENTAL
Intervention: Investigational vaccine (Shan5™)
Number of subjects: 1100
Study: 25713659

Group type: EXPERIMENTAL
Intervention: Nordic-walking training for 8 weeks
Number of subjects: 24
Study: 23549123

Group type: EXPERIMENTAL
Intervention: 30 ml ropivacaine 7.5 mg/ml
Number of subjects: 50

Group type: COMPARATOR
Intervention: 30 ml 0.9% saline
Number of subjects: 50
Study: 19734132

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Denosumab 180 mg
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218